Small Pharma (CVE:DMT) Shares Down 11.1%

Small Pharma Inc. (CVE:DMTGet Rating)’s share price traded down 11.1% during trading on Tuesday . The stock traded as low as C$0.08 and last traded at C$0.08. 12,000 shares traded hands during trading, a decline of 95% from the average session volume of 241,725 shares. The stock had previously closed at C$0.09.

Small Pharma Stock Performance

The firm’s 50-day simple moving average is C$0.07 and its 200 day simple moving average is C$0.09. The company has a market cap of C$24.12 million, a P/E ratio of -0.94 and a beta of 1.97.

Small Pharma Company Profile

(Get Rating)

Small Pharma Inc, a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. Its clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. The company's product includes SPL026 Placebo, which is in clinical Phase IIA for the treatment of major depressive disorder.

Read More

Receive News & Ratings for Small Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Small Pharma and related companies with's FREE daily email newsletter.